332 related articles for article (PubMed ID: 14967447)
1. Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Ono K
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):892-6. PubMed ID: 14967447
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial administration of sodium borocaptate (BSH)/lipiodol emulsion delivers B-10 to liver tumors highly selectively for boron neutron capture therapy: experimental studies in the rat liver model.
Suzuki M; Masunaga S; Kinashi Y; Nagata K; Sakurai Y; Nakamatsu K; Nishimura Y; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):260-6. PubMed ID: 15093923
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion.
Suzuki M; Nagata K; Masunaga S; Kinashi Y; Sakurai Y; Maruhashi A; Ono K
Appl Radiat Isot; 2004 Nov; 61(5):933-7. PubMed ID: 15308171
[TBL] [Abstract][Full Text] [Related]
4. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
5. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma from a viewpoint of dose distribution analysis.
Suzuki M; Sakurai Y; Masunaga S; Kinashi Y; Nagata K; Maruhashi A; Ono K
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1584-9. PubMed ID: 17056195
[TBL] [Abstract][Full Text] [Related]
7. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
8. Intracellular targeting of sodium mercaptoundecahydrododecaborate (BSH) to solid tumors by transferrin-PEG liposomes, for boron neutron-capture therapy (BNCT).
Maruyama K; Ishida O; Kasaoka S; Takizawa T; Utoguchi N; Shinohara A; Chiba M; Kobayashi H; Eriguchi M; Yanagie H
J Control Release; 2004 Aug; 98(2):195-207. PubMed ID: 15262412
[TBL] [Abstract][Full Text] [Related]
9. Impact of accelerator-based boron neutron capture therapy (AB-BNCT) on the treatment of multiple liver tumors and malignant pleural mesothelioma.
Suzuki M; Tanaka H; Sakurai Y; Kashino G; Yong L; Masunaga S; Kinashi Y; Mitsumoto T; Yajima S; Tsutsui H; Sato T; Maruhashi A; Ono K
Radiother Oncol; 2009 Jul; 92(1):89-95. PubMed ID: 19329206
[TBL] [Abstract][Full Text] [Related]
10. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
[No Abstract] [Full Text] [Related]
11. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro evaluation of the phenylboric acid derivative entrapped lipiodol in boron neutron capture therapy for hepatoma.
Chou FI; Chung HP; Shieh MS; Huang CW; Chung RJ; Liu HM; Yang JY; Chi CW; Lin YC; Lui WY; Kai JJ
Anticancer Res; 2003; 23(5A):3955-63. PubMed ID: 14666703
[TBL] [Abstract][Full Text] [Related]
13. Boron-lipiodol: a potential new drug for the treatment of liver tumors.
Lin WY; Chi CW; Ho YJ; Wu IC; Chung YT; Chen SD; Chou FI; Kai JJ; Lui WY; Chen TJ; Lin Y
Anticancer Res; 2002; 22(6C):3989-92. PubMed ID: 12553023
[TBL] [Abstract][Full Text] [Related]
14. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
15. Boron neutron capture therapy at the crossroads: challenges and opportunities.
Barth RF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
[TBL] [Abstract][Full Text] [Related]
16. Feasibility evaluation of neutron capture therapy for hepatocellular carcinoma using selective enhancement of boron accumulation in tumour with intra-arterial administration of boron-entrapped water-in-oil-in-water emulsion.
Yanagie H; Kumada H; Nakamura T; Higashi S; Ikushima I; Morishita Y; Shinohara A; Fijihara M; Suzuki M; Sakurai Y; Sugiyama H; Kajiyama T; Nishimura R; Ono K; Nakajima J; Ono M; Eriguchi M; Takahashi H
Appl Radiat Isot; 2011 Dec; 69(12):1854-7. PubMed ID: 21752660
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):663-72. PubMed ID: 9112465
[TBL] [Abstract][Full Text] [Related]
18. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
[TBL] [Abstract][Full Text] [Related]
19. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
20. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome.
Kageji T; Nagahiro S; Matsuzaki K; Mizobuchi Y; Toi H; Nakagawa Y; Kumada H
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1446-55. PubMed ID: 16750328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]